Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2069]
News [6414]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012
Phase III MISSION trial: Sorafenib does not extend overall survival as third or...
Dr Tony Mok – The Chinese University of Hong Kong
Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )
8 Oct 2012
Personalised cancer medicine and research: Today’s best practice
Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012
Putting drugs to work against brain metastases in HER2 positive breast cancer:...
Dr Thomas Bachelot – Centre Leon Berard, Lyon
Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study ( Dr Thomas Bachelot – Centre Leon Berard, Lyon )
4 Oct 2012
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib
Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012
Highlights from the 2012 NCID Meeting
Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Highlights from the 2012 NCID Meeting ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
23 Jul 2012
Neuroendocrine tumours of the pancreas
Prof Aurel Perren - University of Bern, Switzerland
Neuroendocrine tumours of the pancreas ( Prof Aurel Perren - University of Bern, Switzerland )
23 Jul 2012
International Network of bio-banks and expert centres
Prof Kurt Zatloukal – Institute of Pathology, Medical University of Graz...
International Network of bio-banks and expert centres ( Prof Kurt Zatloukal – Institute of Pathology, Medical University of Graz, Austria )
23 Jul 2012
Translational and tailored, but can we afford it?
Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012
The immuno side of melanoma
Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012
Constructing successful biomarker clinical trials
Dr Lisa McShane – National Cancer Institute, Bethesda, USA
Constructing successful biomarker clinical trials ( Dr Lisa McShane – National Cancer Institute, Bethesda, USA )
16 Jul 2012
Highlights of the 22nd EACR meeting and tackling glioblastoma
Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation